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Abstract 
 
Many diseases including hemochromatosis, chronic anemia, and cirrhosis result in 
abnormal levels of iron stores.  Due to its correspondence with different physiological 
conditions, iron content is often used as a disease marker.  30%-50% of iron storage within the 
body is performed by the protein ferritin.  Currently, there are indirect methods of measuring 
iron content using immuno-detection of iron binding proteins.  The objective of this project is to 
develop a highly sensitive technique that can directly measure iron content based upon the 
magnetic character of iron; the first step is to understand the magnetic characterization of ferritin.  
Magnetic force microscopy (MFM), a mode of the atomic force microscope (AFM), has been 
shown by other research groups and our own group to be a promising method of characterizing 
magnetic particles.  Our research uses this method to characterize ferritin in its iron bound and 
unbound states (termed apoferritin).  MFM uses a magnetized probe to record topographical and 
magnetic information from samples. We compare the widely used medium moment probe to the 
less widely used high moment probe for our project; high moment probes were found to detect 
ferritin proteins with greater sensitivity than medium moment probes.  Our work also reveals that 
MFM can characterize and differentiate between ferritin and apoferritin.  MFM phase data is 
used to measure the iron content of our ferritin samples.  The high resolution and sensitivity of 
MFM makes it a promising method for measuring iron content in blood samples.  
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Introduction 
 
 Abnormal levels of iron storage have been linked to many disorders.  Low iron levels can 
indicate anemia, hypothyroidism, and other deficiencies, while excess iron levels may be caused 
by hemochromatosis, adult-onset Still’s disease, and cirrhosis [1-3].  Because of body iron 
content’s correlation to many diseases, it is often used as a marker for various physiological 
conditions.   Up to fifty percent of the body’s iron stores lie in ferritin, a globular intracellular 
protein that regulates body iron content by controlled loading and release.  Ferritin stores up to 
4500 iron atoms in its hollow core as shown in Figure 1.a [4]. The iron is stored in the Fe(III) 
oxidation state and is released when it is changed to the Fe(II) oxidation state.  When the ferritin 
protein is in its unbound state, it is termed apoferritin (Figure 1.b [5]). 
 
 
 
 
 
 
 
 
 
 
 
The amount of ferritin present in body is usually proportional to the amount of stored 
iron.  There are a few currently available tests that exploit this proportionality through immuno-
Figure 1. a) Ferritin protein with iron stored in its hollow core [4]. b) Apoferritin protein, 
ferritin without bound iron [5]. 
a) b) 
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detection of ferritin. Serum ferritin test is one of the most commonly used iron content assays, 
but it has limitations.  Serum ferritin tests can be unreliable as an iron content indicator because 
serum ferritin levels are affected by inflammation, infection, and ascorbate deficiency [6-8].  
Under these conditions, ferritin may be upregulated in the apoferritin( ironless) state, or with 
lower or higher than normal iron atoms bound to its core.  Serum ferritin test measures the 
amount of ferritin in a sample (both apoferritin and iron bound ferritin), but cannot distinguish 
between the two.  In these cases, the amount of ferritin (apo and iron-bound) measured by the 
serum ferritin test will not be proportional to the amount of iron in the body.   
Our goal is to develop a procedure that will directly measure the iron content in blood 
based upon the magnetic character of iron rather than immuno-detection.  Current iron 
magnetism-based techniques include MRI and biosusceptometry, but these two methods are not 
sensitive enough as they can only detect large quantities on the order of milligrams, while body 
iron content is on the order of micrograms.  Superconducting quantum interference device 
(SQUID) magnetometry is another method of measuring Fe content, but due to its complexity 
and cost, its usage is limited.  From previous studies, it was found that magnetic force 
microscopy (MFM), an atomic force microscopy technique, can detect and quantify magnetic 
moments of single and aggregate superparamagnetic nanoparticles (SPNs) [9-11].  In this study, 
we employed a similar MFM technique to characterize ferritin and apoferritin at the single 
particle level. 
MFM is a specialized atomic force microscopy (AFM)-based technique that maps the 
magnetic force gradient above a sample surface without making direct contact with the sample.  
This is performed using a two pass technique termed LiftMode.  In LiftMode, a probe makes two 
passes over one area of a sample.  The first pass collects topographical (height) data, while the 
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second pass uses this data to maintain the probe tip at a constant specified height (lift height) 
above the sample surface for long-range magnetic force data collection (Figure. 2a).  The 
magnetic field gradient above the sample induces changes in the cantilever’s resonance 
frequency or phase, which is recorded as an amplitude or a phase shift measurement (Figure 2b 
[12]).  These measurements are then compiled by the AFM program and rendered as an image.  
We can use the phase shift measurements to analyze magnetic moment strength and iron content 
of the sample. 
 
 
 
The magnetic force data is collected by a probe coated with a ferromagnetic thin film.  
Multiple types of magnetic probes can be utilized for MFM imaging.  Most current research 
employs medium moment (1e-13 emu) probes.  Less widely used are high moment (3e-13 emu), 
probes, which are have a stronger magnetic moment and therefore should be more sensitive to 
interaction with magnetic samples [9].  This study will utilize both probe types and compares 
Figure 2.  a) MFM liftmode. Pass 1 
meaures topography. Pass 2 measures 
magnetic force [12]. b) Magnetic probe-
sample interaction [12]. 
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their relative abilities to collect magnetic data from ferritin. We then use MFM to detect and 
characterize the magnetic moments and iron content of ferritin, apoferritin and mixed samples.  
  
Objective 1: Compare the relative abilities of high magnetic moment probes and medium 
magnetic moment probes to image ferritin using magnetic force microscopy 
 
Objective 2:  Use MFM to distinguish ferritin from apoferritin, and characterize the proteins’ 
magnetic properties. 
Methods   
Sample Preparation 
 
Ferritin, apoferritin, and mixed samples were synthesized using a series of dilutions.   
The ferritin samples were produced from a stock solution of 85 mg/mL horse spleen ferritin 
(SIGMA).  11.76 uL of the base solution was diluted with 1 mL DI water and then vortex mixed 
(Vortex Genie Scientific Instruments) for 10 seconds.  0.5 uL of the new solution is diluted with 
1 mL distilled water and then votex mixed for another 10 seconds.  The vortex mixing is crucial 
to sample preparation because it separates conglomerates of ferritin into individual proteins.  
This procedure creates a final ferritin concentration of 0.5 ug/mL.  The apoferritin samples are 
produced from a stock solution of 47.4 mg/mL horse spleen apoferritin (SIGMA).  There are two 
dilutions in which the stock solution of apoferritin is first diluted to 0.55 mg/mL and then to 0.22 
ug/mL.  10 seconds of vortex mixing was performed after each dilution.  The mixed 
apoferritin/ferritin sample was created by mixing equal amounts of the apoferritin and ferritin 
samples; the combination was then vortex mixed for 10 seconds.  The final concentrations were 
chosen to minimize formation of large conglomerates so that individual proteins can be 
characterized.  30 uL of each liquid sample was immediately aliquoted onto freshly cleaved mica 
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substrate (ruby muscovite, S&J Trading) and was allowed to dry overnight under ambient 
conditions. 
Magnetic Force Microscopy 
 
MFM imaging was conducted using a Multimode AFM in conjuction with a Nanoscope 
IIIa controller and Quadrex Extender (Digital Instruments).  The proteins were imaged with an 
applied magnetic field of ~2000 G, emitting from the magnet at the base of the Multimode AFM 
[9].  We used NSC18/CoCr (Micro Masch) medium moment probes and CoCr ASYHMFM 
(Asylum Research) high moment probes.  To increase the magnetic sensitivity, each probe was 
pre-magnetized with a permanent magnet for ~1 minute.  The medium moment probes were 
auto-tuned to a resonance frequency of approximately 70 kHz with a 5% offset for main controls 
and 0% offset for interleave controls.  The high moment probes were auto-tuned to a resonance 
frequency of approximately 90 kHz with the same offset settings as the medium moment probes.  
Tapping mode was used at a scan rate of 2 Hz and with 512 lines/scan direction.  Topographical 
height images were collected in the main scan while the phase images were collected in the 
interleave lift mode at various lift heights (10 nm – 100 nm). Images collected from the AFM 
were flattened and analyzed using the section analysis tools in the NanoScope Analysis software 
(Digital Instruments).  Multiple independent experiments were conducted per sample type and n 
= 50 particles from each sample type were analyzed.   
Results 
MFM of Ferritin 
 
Magnetic force microscopy was performed on ferritin to test if it was a viable technique 
for quantifying iron levels in blood.  The average diameter (d) measured by medium moment 
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probes was 95.9 nm, while the average diameter measured by high moment probes was 105.6 
nm.  The diameters are inflated because in tapping mode, the lateral dimension is distorted due to 
the tip-sample convolution effect.  The true diameter (2r) of our ferritin protein was found using 
the geometric de-convolution equation [9]. 
 
   √    (1) 
 
The average radius (R) of our high moment MFM probe was ~110 nm, as denoted by the 
manufacturer.  We found that the true diameter of the ferritin particle was ~7.2 nm.  Data for 
ferritin was collected with both medium moment and high moment probes examining whether 
high moment probes were significantly more sensitive than their medium moment counterparts. 
The images in Figure 3 compares phase and height images collected at different lift heights with 
medium moment probes to those collected with high moment probes.  To quantify the difference 
in sensitivities of the two probes, we measured the phase shift of individual ferritin particles and 
plotted the average values against the lift height in Figure 4. 
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Figure 3. a) Height and phase shift images of ferritin captured at different lift heights using medium moment probe.   
b) Height and phase shift images of ferritin captured at different lift heights using high moment probe.  These images 
indicate that the MFM technique is a viable means of detecting the magnetic moment of ferritin.  Both samples indicate 
that the phase shift signal decreases as lift height increases, but the signal of the medium moment probe decreases at a 
much higher rate.  It is possible to collect phase images up to 30 nm lift height using the medium moment probe, while 
high moment probes can capture images at up to 60 nm lift height. Height image qualities are similar. 
Phase: Lift Height 20 nm 
nm 
Phase: Lift Height 30 nm  
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As shown by the quantitative and graphical data, although the phase shift of both medium and 
high moment probes decreases as lift height increases, the maximum lift height at which signals 
could be measured is much greater for high moment probes (50 nm) than medium moment 
probes (30 nm).  Because of the significant difference in signal detection, the rest of our 
experiments were conducted using the high moment probe.  
MFM of Apoferritin  
 
To understand the differences between ferritin in its bound state and unbound state, we 
also analyzed apoferritin with the MFM technique.  The height image and the phase images are 
shown in Figure 5.  
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Figure 4. Plot of phase shift data as a function of lift height collected using high 
moment and medium moment probes. Similar to the graphical data, the numerical 
data shows a decreasing relationship between lift height and phase shift.  While both 
medium moment and high moment probes start at similar phase values, medium 
moment probes lose their ability to image at 30 nm while high moment probes loses 
its ability at 60 nm. 
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The average diameter found for apoferritin was similar to that of ferritin at 7.4 nm.  Figure 6 
compares the phase shifts of ferritin and apoferritin as a function lift height.   
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Figure 6. Phase shift plot over lift height for ferritin and apoferritin.  As the graphical data 
suggests, the magnetic moment of apoferritin is much lower than that of ferritin. 
100 
0 
Figure 5 Height and phase shift images of apoferritin at various lift heights collected with a high moment probe. 
Apoferritin phase shift decreases much faster than ferritin. 
Phase: Lift Height 30 nm  Phase: Lift Height 20 nm  Topographical Height  
1 um 
16 
 
MFM of Mixed Apoferritin and Ferritin  
 
A sample where ferritin and apoferritin was mixed was imaged using the MFM technique 
because in humans, apoferritin may exist in the bound and unbound states simultaneously. Figure 
8 compares the height and phase images of the same sample at 20 nm lift height, where ferritin 
and apoferritin can be easily distinguished.  Every ferritin particle bound or unbound  shows up 
as a bright dot on the height image, but only iron loaded ferritin will be bright on the phase 
image. In Figure 7, yellow circles denote ferritin in their respective height and phase images 
while red circles denote apoferritin.  The average true diameter of the ferritin and apoferritin 
were 7.3 nm and 7.4 nm respectively.   
 
 
 
 
Figure 7. Height topographical image and phase shift image of mixed solution at 20 nm lift height.  The difference 
between ferritin and apoferritin in the mixed sample can be easily seen.  Red circles indicate corresponding apoferritin 
particles, while yellow circles indicate corresponding ferritin particles. 
Ferritin Apoferritin 
50 
-50 
1 um 
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Magnetic Property Characterization of Ferritin 
 
A series of equations were used to convert the magnetic phase shift data into magnetic 
moment.  The relationship between lift height, phase shift, and sample magnetic moment can be 
described by the equation [11]: 
 
    
  
  
    
  
 
 
        
    
   
 
  (2) 
 
Where µ0 is the permeability constant of a vacuum, k (high moment: 2 N/m, medium moment: 
2.8 N/m) is the spring constant of the MFM cantilever, Q (high moment: 270, medium moment: 
380) is quality factor, d is the diameter of the ferritin protein, R is the outer shell radius of the 
MFM probe (high moment: 110 nm, medium moment: 90 nm), c is the thickness of the Cr layer 
preventing oxidation of the magnetic coating (high moment: 30 nm, medium moment: 20 nm), s 
is the lift height, ms is the particle magnetic moment, and mp is the probe magnetic moment, 
given as [10]: 
 
    
 
 
       
     (3) 
 
where Mp (1.4e6 A m
-1
)
[10]
 is the saturation magnetization of Co coating on the MFM cantilever 
and R1 is the inner shell radius of the MFM probe (~10nm). 
Using equation 2 and data collected with the high moment probe, we found that the 
average magnetic moment of an individual ferritin protein, ms, was 3.77e-17 A m
2
 (range: 2.71e-
17 A m
2 – 3.33e-17 A m2).  The moment of an individual apoferrtin protein was 8.08e-18 A m2 
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(range: 1.95e-18 A m
2
 – 2.59e-17 A m2).  In the mixed sample, the average magnetic moment of 
ferritin and apoferritin at 20 nm lift height were 2.31e-17 Am
2
 and 4.96e-18 Am
2
.  A summary of 
our measurements is shown in Tables 1 and 2.   
 
Table 1. Summary of data for Ferritin and Apoferritin trials. 
 
Ferritin Apoferritin 
Diameter (nm) 7.2 7.3 
Rng. Magnetic Moment (Am^2) 2.71e-17 - 3.33e-17 1.95e-18 – 2.59e-17 
Ave. Magnetic Moment (Am^2) 3.77e-17 8.08e-18 
 
Table 2. Summary of data for mixed solution trials. 
 Ferritin Apoferritin 
Ave. Magnetic Moment (Am
2
)
 2.31e-17 4.96e-18 
 
Discussion  
 
 Prior studies have confirmed that the MFM technique can be used to detect 
superparamagnetic nanoparticles [9].  In this work, we used magnetic force microscopy to 
characterize single ferritin and apoferritin proteins as part of a greater goal of developing a 
technique for measuring the iron content of ferritin in the blood. Our research revealed that the 
MFM technique can detect single ferritin proteins across a wide range of lift heights.  In a 
comparison of medium moment and high moment probes, we found that high moment probes 
can detect magnetic signals at much greater lift heights (60 nm) than medium moment probes (30 
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nm).  The difference in magnetic moment sensitivity will be important when developing a 
technique for characterizing magnetic properties of liquid samples, such as blood.  This is 
usually difficult because when an AFM probe is placed inside a liquid, probe movement is 
dampened and measurement accuracy is low.  If we are able to characterize a liquid sample from 
a distance, then dampening will not be an issue.  Because of the difference in sensitivity, the rest 
of the experiment was conducted using high moment probes. 
 Our MFM studies characterized ferritin proteins as spherical shells with lateral diameters 
of 7.4 nm, which is smaller than 13 nm found by previous studies [13].  This might be due to 
differences in calibration of the atomic force microscope or differences in sample preparation.  
For our procedure, distilled water was used to dilute the base ferritin solution, but ferritin’s shell 
is hydrophobic.  The hydrophobic forces might have then compressed the ferritin shell, reducing 
its diameter and height.   
Using equation 2 and our phase shift data, we calculated that the average magnetic 
moment of individual ferritin proteins was 3.77e-17A m
2
.  This value is similar to the 3.7e-17 A 
m
2
 that was found by an MFM study of similarly sized superparamagnetic nanoparticles [9].  
However, SQUID analysis found a slightly different magnetic moment values.  Using a 
magnetization curve shown in Figure 8 [], we find that the magnetization of ferritin using a 
2000G magnetic field is ~0.05 emu/g, which translates into 1.68e-20 A m
2
.  These values 
indicate consistency among MFM characterizations of ferritin, but differences between MFM 
measurements and SQUID measurements.  Further optimization of the MFM technique is 
necessary to bridge this discrepancy. 
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Figure 8. Magnetization graph for ferritin. [] 
 MFM studies on apoferritin recorded lateral diameters of 7.41 nm, which is similar to our 
ferritin measurements.  As expected, the magnetic moment of apoferritin (8.08e-18 A m
2
) is 
much lower than the values measured for ferritin at an average value of 3.77e-17 A m
2
, but it 
was not at 0 A m
2
.  MFM Appoferritin’s magnetic moment is probably not caused by the 
presence of iron particles, but rather it was due to van der waals and other short range 
interactions.  To obtain the true magnetic moment of ferritin, we subtracted the 8.08e-18 A m
2
 
caused by unrelated short range forces from both ferritin and apoferritin to achieve final results 
of 3.69e-17 Am
2
 and 0 Am
2
.   
 
Results from the apoferritin study confirm that the MFM 
technique can accurately characterize apoferritin and differentiate separate samples of ferritin 
and apoferritin. 
 Because blood carries both apoferritin and ferritin, we conducted MFM on mixed 
apoferritin ferritin solutions.  Figure 9 shows that the MFM technique is sensitive enough to 
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differentiate between ferritin and apoferritin.  Significant differences between ferritin and 
apoferritin magnetic moment can be found (2.31-17 A m
2
 vs. 4.96e-18 A m
2
).  The magnetic 
moment of ferritin was lower than expected, which might indicate that some of the iron was 
picked up from the ferritin by the apoferritin during the preparation process.  Overall, the MFM 
technique shows promise as an accurate method of ferritin characterization. 
Conclusion 
 
 In summary, we demonstrated here that MFM can accurately identify and characterize 
both ferritin and apoferritin.  Magnetic phase shift measurements can be collected at greater lift 
heights when using high moment probes rather than the more widely used medium moment 
probes.  If we are to image ferritin in blood, high moment probes will be necessary for iron 
detection.  The MFM technique has enough sensitivity to quantitatively differentiate between 
ferritin and apoferritin in mixed solutions.  Magnetic moment measurements will allow direct 
measurements of iron content for disease diagnosis.  We conclude that MFM is a viable method 
of ferritin characterization and iron quantification; the ability to capture magnetic data without 
direct contact to the sample makes magnetic force microscopy a promising technique for 
biological samples like blood in the future.  
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